LeonaBio (LONA) Net Cash Flow (2019 - 2026)
LeonaBio (LONA) reported Net Cash Flow of -$36.4 million for Q1 2026, down 65.53% year-over-year from -$105.7 million in Q1 2025, and down 175.29% on a QoQ basis from $48.4 million in Q4 2025.
LeonaBio (LONA) has 8 years of Net Cash Flow data on file, last reported at -$36.4 million in Q1 2026.
- Quarterly Net Cash Flow fell 65.53% year-over-year to -$36.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.4 million (up 112.39% YoY) and the FY2025 annual result came in at $20.8 million, up 149.44% from the prior year.
- Net Cash Flow slipped to -$36.4 million in Q1 2026 per LONA's latest filing, from $48.4 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $48.4 million in Q4 2025 and bottomed at -$36.4 million in Q1 2026.
- The 5-year median for Net Cash Flow is -$5.0 million (2024), against an average of -$4.5 million.
- The widest annual swing landed in 2022, when Net Cash Flow sank 686.75%; it then surged 268.12% in 2025.
- Tracing LONA's Net Cash Flow over 5 years: stood at $9.1 million in 2022, then plunged by 316.39% to -$19.8 million in 2023, then tumbled by 45.78% to -$28.8 million in 2024, then surged by 268.12% to $48.4 million in 2025, then sank by 175.29% to -$36.4 million in 2026.
- Per Business Quant, the three latest LONA Net Cash Flow figures stand at -$36.4 million (Q1 2026), $48.4 million (Q4 2025), and $986000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 60.68 Mn |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - | -36.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.44 Mn |
| Mar 31, 2026 | -36.44 Mn |
| Dec 31, 2025 | 48.40 Mn |
| Dec 31, 2025 | 48.40 Mn |
| Sep 30, 2025 | 986,000.00 |
| Sep 30, 2025 | 986,000.00 |
| Jun 30, 2025 | -6.56 Mn |
| Jun 30, 2025 | -6.56 Mn |
| Mar 31, 2025 | -22.02 Mn |
| Mar 31, 2025 | -22.02 Mn |
| Dec 31, 2024 | -28.79 Mn |
| Dec 31, 2024 | -28.79 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Jun 30, 2024 | 4.23 Mn |
| Jun 30, 2024 | 4.23 Mn |
| Mar 31, 2024 | -12.76 Mn |
| Mar 31, 2024 | -12.76 Mn |
| Dec 31, 2023 | -19.75 Mn |
| Dec 31, 2023 | -19.75 Mn |
| Sep 30, 2023 | -3.29 Mn |
| Sep 30, 2023 | -3.29 Mn |
| Jun 30, 2023 | 8.45 Mn |
| Jun 30, 2023 | 8.45 Mn |
| Mar 31, 2023 | 9.43 Mn |
| Mar 31, 2023 | 9.43 Mn |
| Dec 31, 2022 | 9.13 Mn |
| Dec 31, 2022 | 9.13 Mn |
| Sep 30, 2022 | -8.01 Mn |
| Sep 30, 2022 | -8.01 Mn |
| Jun 30, 2022 | -22.75 Mn |
| Jun 30, 2022 | -22.75 Mn |
| Mar 31, 2022 | 7.48 Mn |
| Mar 31, 2022 | 7.48 Mn |
| Dec 31, 2021 | 3.21 Mn |
| Dec 31, 2021 | 3.21 Mn |
| Sep 30, 2021 | -24.37 Mn |
| Sep 30, 2021 | -24.37 Mn |
| Jun 30, 2021 | 3.88 Mn |
| Jun 30, 2021 | 3.88 Mn |
| Mar 31, 2021 | 67.20 Mn |
| Mar 31, 2021 | 67.20 Mn |
| Dec 31, 2020 | -105.10 Mn |
| Dec 31, 2020 | -105.10 Mn |
| Sep 30, 2020 | 80.56 Mn |
| Sep 30, 2020 | 80.56 Mn |
| Jun 30, 2020 | 82.44 Mn |
| Jun 30, 2020 | 82.44 Mn |
| Mar 31, 2020 | 666,000.00 |
| Mar 31, 2020 | 666,000.00 |
| Dec 31, 2019 | -224,000.00 |
| Dec 31, 2019 | -224,000.00 |